Abstract Within the World Health Organization (WHO) classification of haematopoietic
neoplasms, particularly its fifth version from 2022 (WHO-HAEM5), myeloid neoplasms are …

In recent years, technology developments and increase in knowledge have led to profound
changes in the diagnostics of haematologic neoplasms, particularly myeloid neoplasms …

The landscape of haematological malignancies is constantly evolving, driven by advances
in our understanding of their genetic basis. This has cumulated within the 5th Edition of the …

Since the publication of the latest World Health Organization (WHO) classification in 2008,
there has been a significant effort for clarification of unresolved questions, especially with …

This study aimed to assess hematological diseases next-generation sequencing (NGS)
panel enhances the diagnosis and classification of myeloid neoplasms (MN) using the 5th …

In this manuscript, we review myeloid neoplasms in the 5 th edition of the World Health
Organization classification of hematolymphoid tumors (WHO-HEM5), focusing on changes …

There is no single category in the fourth edition (2008) of the World Health Organization
(WHO) classification of myeloid neoplasms that encompasses all of the diseases referred to …

In this article we provide a practical and comprehensive review of myeloid neoplasms with
overlapping myelodysplastic (MDS) and myeloproliferative (MPN) features, with emphasis …

Background: According to the 2016 WHO classification, Ph-negative MPN include essential
thrombocythemia (ET), polycythemia vera (PV), prefibrotic myelofibrosis (prePMF) and overt …

With the emergence of the 5th edition of the World Health Organization (WHO) Classification
of Haematolymphoid Tumours (WHO-HAEM5)[1, 2], we again witness a groundbreaking …